RRM2 and Friedreich ataxia: To investigate the susceptibility of nonmalignant cells, we analyzed the viability score after RRM1 and RRM2 knockdown in primary non-transformed oral (PO) fibroblasts from two healthy donors (donors #50 and #54) and from an FA patient (VU-1678).